BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martínez-Castelao A, Cases A, Carballada AT, Iranzo JT, Bronsoms J, Vallès-Prats M, Monserrat DT, Jimenez EM; investigators of the ACERCA Study Group. Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study. Nefrologia 2015;35:179-88. [PMID: 26300512 DOI: 10.1016/j.nefro.2015.05.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Yoon S, Rhee SJ, Heo SJ, Oh TY, Yoon SH, Cho JY, Lee S, Yu KS. Comparable pharmacokinetics and pharmacodynamics of two epoetin alfa formulations Eporon® and Eprex® following a single subcutaneous administration in healthy male volunteers. Drug Des Devel Ther 2017;11:3127-35. [PMID: 29138535 DOI: 10.2147/DDDT.S142673] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
2 Kim S, Hong T, Ko JW, Huh W, Kim JR. Comparison of the Pharmacokinetic-Pharmacodynamic Relationships of Two Darbepoetin Alfa Formulations in Healthy Male Volunteers. BioDrugs 2019;33:101-12. [PMID: 30506495 DOI: 10.1007/s40259-018-0323-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]